Philip Morris seen landing IQOS risk claim despite setback
Jan. 25, 2018 12:56 PM ETPhilip Morris International Inc. (PM)PMBy: Clark Schultz, SA News Editor27 Comments
- Height Securities analyst Stefanie Miller thinks Philip Morris International (PM -2.2%) is likely to end up with FDA approval for its IQOS risk claim.
- Miller says the advisory committee that ruled today was too "unprepared" and "inexperienced" to do anything but act as a roadblock. She also points out that the panel's recommendation is non-binding.
- Philip Morris is looking for the modified risk tobacco product designation from the agency to help market IQOS products.
- Previously: FDA rejects Philip Morris IQOS claims (Jan. 25)